Loading candles…
Entero Healthcare Solutions Ltd, incorporated in 2018, operates in the healthcare and pharmaceutical distribution industries in India. The company functions as a large-scale distributor of healthcare products, providing an integrated platform to generate demand and fulfill supply requirements. It acts as an intermediary between healthcare product manufacturers and an extensive network of retail pharmacies and hospitals, utilizing a technology-driven supply chain. Its business segments include the distribution and marketing of pharmaceutical and surgical products, alongside allied services. The product portfolio encompasses pharmaceutical products, surgical products, medical devices, surgical consumables, and over-the-counter products. The company does not have any listed subsidiaries or ventures, nor is it listed on any stock exchange.
This page is a live market overview for ENTERO HEALTHCARE SOLU L (ENTERO) on the NSE. As a listed security, ENTERO HEALTHCARE SOLU L is tracked in the Consumer Services segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ENTERO before placing trades on tick2trade.
As of the latest feed, ENTERO last traded at ₹1,242.7 on NSE, up ₹0.2 (0.02%) from the previous close of ₹1,242.5. Today's session range is ₹1,230 – ₹1,266, against a 52-week band of ₹944 – ₹1,390. Traded volume today stands at 46.03K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for ENTERO in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ENTERO is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ENTERO HEALTHCARE SOLU L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ENTERO. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ENTERO option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 7 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and other business matters | 25 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 12 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 12 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended June 30, 2025 | 8 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 27 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.